Severe Atopic Dermatitis (AD)
1 clinical trials · Condition
◉ Watch Severe Atopic Dermatitis (AD)
| Record | Firm | Date |
|---|---|---|
| Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab (NCT07187089) | Regeneron Pharmaceuticals | 2025-11-11 |
Track Severe Atopic Dermatitis (AD) automatically
Every clearance here is in the API, with alerts when new ones post.